Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
for Acneiform Eruption Due to Chemical
Sites in New Hyde Park, Mineola +7 more locations
Sponsor: Hoth Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05639933·Phase 2·Recruiting·Listed Dec 2022